An unspecific immunostimulating agent and juvenile dermatomyositis: enhanced T-cell proliferation and reverse immunosuppression as a severe adverse drug reaction.
Lackmann
Gerd M
GM
Paediatric Practice, Reinstorfweg 10a, 21107 Hamburg, Germany. GMLackmann@t-online.de
Ndagijimana
Jenny
J
Niehues
Tim
T
D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000627:therapeutic use; D001565:Benzoates / Q000009:adverse effects*; D002648:Child; D003882:Dermatomyositis / Q000188:drug therapy* / Q000276:immunology; D018450:Disease Progression; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007288:Inosine / Q000009:adverse effects*; D007542:Inosine Pranobex; D008279:Magnetic Resonance Imaging; D013601:T-Lymphocytes / Q000276:immunology*
D000276:Adjuvants, Immunologic; D001565:Benzoates; C481876:Delimmun; D004338:Drug Combinations; D007288:Inosine; D007542:Inosine Pranobex